Thursday, June 25, 2015 2:07:14 AM
BioMaterials...
Another category of supermaterials that will become a household name in the next few years is biomaterials, materials that seamlessly work with our bodies' natural biological cells and membranes. Biomaterials can mimic cells, tissue, and muscle, effectively replacing them in our bodies. Plus, they aren't foreign substances to our bodies like metal and plastic are. The global market for biomaterials should reach $115 billion by 2020, with a growth rate of more than 13%, according to biomaterials research firm Mordor Intelligence.
Amedica Corporation (Amedica) is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company markets spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a complementary line of non-silicon nitride spinal fusion products which allows us to provide surgeons and hospitals with a broader range of products. These products include three lines of spinal fusion devices and five types of orthobiologics, which are used by surgeons to help promote bone growth and fusion in spinal fusion procedures.
Another category of supermaterials that will become a household name in the next few years is biomaterials, materials that seamlessly work with our bodies' natural biological cells and membranes. Biomaterials can mimic cells, tissue, and muscle, effectively replacing them in our bodies. Plus, they aren't foreign substances to our bodies like metal and plastic are. The global market for biomaterials should reach $115 billion by 2020, with a growth rate of more than 13%, according to biomaterials research firm Mordor Intelligence.
Amedica Corporation (Amedica) is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company markets spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a complementary line of non-silicon nitride spinal fusion products which allows us to provide surgeons and hospitals with a broader range of products. These products include three lines of spinal fusion devices and five types of orthobiologics, which are used by surgeons to help promote bone growth and fusion in spinal fusion procedures.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
